← Eichor
Condition: Severe Bacterial Infections Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Severe Bacterial Infections

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa
Phase 2 · 1 location(s) · Sinocelltech Ltd. · NCT07244510A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participant
Phase 3 · 285 location(s) · AbbVie · NCT05889182Management of Shock in Children With SAM or Severe Underweight and Diarrhea
Phase 3 · 1 location(s) · International Centre for Diarrhoeal Disease Research, Bangla · NCT04750070Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
Phase 3 · 31 location(s) · Major Extremity Trauma Research Consortium · NCT04678154Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis S
Phase 2 · 30 location(s) · Incyte Corporation · NCT07213973Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
Phase 2 · 79 location(s) · Sanofi · NCT07170917Atmospheric Pressure Cold Plasma for Moderate-to-severe Tinea Pedis
NA · 1 location(s) · Shenyang Medical College · NCT07056660A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
Phase 2/Phase 3 · 58 location(s) · Bluefin Biomedicine, Inc. · NCT07287644Secukinumab Treatment for Moderate to Severe Hidradenitis Suppurativa
Phase N/A · 1 location(s) · Peking Union Medical College · NCT07109765A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps
Phase 2 · 71 location(s) · Pfizer · NCT07228390A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx®
Phase 1 · 14 location(s) · UCB Biopharma SRL · NCT06888193Fosfomycin I.v. for Treatment of Severely Infected Patients
Phase N/A · 50 location(s) · Infectopharm Arzneimittel GmbH · NCT02979951A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Sup
Phase 2 · 66 location(s) · Sanofi · NCT07225569A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Phase 2 · 41 location(s) · Navigator Medicines, Inc. · NCT07384975Real-world Secukinumab Outcomes in Canadian HS Patients
Phase N/A · 15 location(s) · Novartis Pharmaceuticals · NCT07282015Optimising Kangaroo Care to Reduce Neonatal Severe Infection/Sepsis and Resistant Bacterial Colonisation Among High-risk
NA · 24 location(s) · PENTA Foundation · NCT05993442A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to S
Phase 1 · 1 location(s) · Shanghai Qilu Pharmaceutical Research and Development Center · NCT06946641Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Phase N/A · 1 location(s) · Brain Inflammation Collaborative · NCT04806620The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood Tuberculosis
NA · 29 location(s) · Chishala Chabala · NCT06593080A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Phase 2 · 49 location(s) · Takeda · NCT07244263Oropharyngeal Candidiasis (OPC) and S-ECC
Phase N/A · 1 location(s) · Temple University · NCT05761197Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis
Phase N/A · 2 location(s) · Qianfoshan Hospital · NCT07530770A Study of LAD191 in Adults With Hidradenitis Suppurativa
Phase 2 · 1 location(s) · Almirall, S.A. · NCT07151937A Combination Therapy With Ceftazidime and Fosfomycin Will be Compared to Ceftazidime Alone in Hospitalized Adult Patien
Phase 3 · 1 location(s) · Angela HUTTNER · NCT07063095Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adul
Phase N/A · 16 location(s) · Novartis Pharmaceuticals · NCT07543419A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Pre
Phase 3 · 62 location(s) · Grifols Therapeutics LLC · NCT05645107Identification of Clinical, Genetic and Immunological Factors Involved in the Development of Severe Bacterial Infections
NA · 6 location(s) · Nantes University Hospital · NCT07111793Treating Severe Mitral Valve Annular or Valvular Calcification Using Shockwave Balloon SMARTWAVE
NA · 1 location(s) · Prince of Wales Hospital, Shatin, Hong Kong · NCT06952374Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis
Phase N/A · 1 location(s) · University of Ulm · NCT03044223Pharmacokinetic Analysis of Cefiderocol in Patients With Acute Burn Injuries
Phase 4 · 1 location(s) · University of Tennessee · NCT07465432
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.